MAIER PAUL V
CIK: 0001182615
Director
Primary company: LIGAND PHARMACEUTICALS INC (LGND)
MAIER PAUL V is a corporate insider at LIGAND PHARMACEUTICALS INC (LGND) filing SEC Form 4 transactions. 367 transactions across 11 companies, totaling $78,784 in purchases and $2,599,352 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Exercise | 12,500 | $7.31 | $91K | 0 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Exercise | 50,000 | $3.78 | $189K | 0 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Exercise | 12,500 | $7.31 | $91K | 72,245 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 128 | $61.77 | $8K | 59,745 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 13,485 | $60.21 | $812K | 59,873 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 36,387 | $58.64 | $2.13M | 73,358 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Exercise | 50,000 | $3.78 | $189K | 109,745 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Exercise | 50,000 | $3.78 | $189K | 0 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 128 | $61.77 | $8K | 59,745 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 13,485 | $60.21 | $812K | 59,873 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Sale | 36,387 | $58.64 | $2.13M | 73,358 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
| Exercise | 50,000 | $3.78 | $189K | 109,745 | 8/28/2026 Filed: 8/28/2026 | Filing → | |
International Stem Cell CORP ISCO | Award | 182,584 | $0.18 | $32K | 182,584 | 6/11/2026 Filed: 6/11/2026 | Filing → |
International Stem Cell CORP ISCO | Award | 30,000 | $0.17 | $5K | 30,000 | 6/11/2026 Filed: 6/11/2026 | Filing → |
International Stem Cell CORP ISCO.OB | Award | 532,786 | - | - | 532,786 | 6/17/2025 Filed: 6/20/2025 | Filing → |
International Stem Cell CORP ISCO.OB | Award | 30,000 | - | - | 30,000 | 6/17/2025 Filed: 6/20/2025 | Filing → |
| Award | 25,000 | $13.00 | $325K | 25,000 | 1/3/2025 Filed: 1/6/2025 | Filing → | |
International Stem Cell CORP ISCO.OB | Award | 361,111 | - | - | 361,111 | 6/11/2024 Filed: 6/13/2024 | Filing → |
International Stem Cell CORP ISCO.OB | Award | 30,000 | - | - | 30,000 | 6/11/2024 Filed: 6/13/2024 | Filing → |
Ambrx Biopharma, Inc. AMAM | Disposition | 15,000 | - | - | 0 | 3/7/2024 Filed: 3/7/2024 | Filing → |
Type
Exercise
Shares
12,500
Price
$7.31
Value
$91K
Type
Exercise
Shares
50,000
Price
$3.78
Value
$189K
Type
Exercise
Shares
12,500
Price
$7.31
Value
$91K
Type
Sale
Shares
128
Price
$61.77
Value
$8K
Type
Sale
Shares
13,485
Price
$60.21
Value
$812K
Type
Sale
Shares
36,387
Price
$58.64
Value
$2.13M
Type
Exercise
Shares
50,000
Price
$3.78
Value
$189K
Type
Exercise
Shares
50,000
Price
$3.78
Value
$189K
Type
Sale
Shares
128
Price
$61.77
Value
$8K
Type
Sale
Shares
13,485
Price
$60.21
Value
$812K
Type
Sale
Shares
36,387
Price
$58.64
Value
$2.13M
Type
Exercise
Shares
50,000
Price
$3.78
Value
$189K
International Stem Cell CORP
ISCO
Type
Award
Shares
182,584
Price
$0.18
Value
$32K
International Stem Cell CORP
ISCO
Type
Award
Shares
30,000
Price
$0.17
Value
$5K
International Stem Cell CORP
ISCO.OB
Type
Award
Shares
532,786
Price
-
Value
-
International Stem Cell CORP
ISCO.OB
Type
Award
Shares
30,000
Price
-
Value
-
Type
Award
Shares
25,000
Price
$13.00
Value
$325K
International Stem Cell CORP
ISCO.OB
Type
Award
Shares
361,111
Price
-
Value
-
International Stem Cell CORP
ISCO.OB
Type
Award
Shares
30,000
Price
-
Value
-
Ambrx Biopharma, Inc.
AMAM
Type
Disposition
Shares
15,000
Price
-
Value
-
AI Agent
Try asking...